✦ LIBER ✦

Long-term safety and tolerability of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate to severe psoriasis: Results from a phase III, randomized, controlled trial (ESTEEM 1)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apremilast, an oral phosphodiesterase 4

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Apremilast, an oral phosphodiesterase 4

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Improvements in patient-reported outcome

✍ Vibeke Strand, David Fiorentino, ChiaChi Hu… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 457 KB

Efficacy and safety of efalizumab in pat

✍ NAYAK, A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 27 KB

Efficacy and safety of efalizumab in a l

✍ Kenneth Gordon; David Pariser; Richard Langley; Ivor Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Efficacy and safety results from a phase

✍ B.E. Strober; J.J. Crowley; P.S. Yamauchi; M. Olds; D.A. Williams 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB